Probiotics, allergy, and asthma;Probiotiká, alergia a astma

Alergie

Volumn 5, Issue 3, 2003, Pages 224-230

  Ferenčík, Miroslav ^a,c   Ebringer, Libor ^b  

^a Imunol Ustav Lekarskej Fakulty UK   (Slovakia)

^b Ustav Bunkovej Biol   (Slovakia)

^c NONE   (Slovakia)

Author keywords

Atopic and non atopic phenotype; Pathogenesis of atopic diseases; Probiotics immunobiotics; Regulatory and suppressor cytokines; Toll like receptors

Indexed keywords

PROBIOTIC AGENT; SELENIUM; TOLL LIKE RECEPTOR;

ALLERGIC ASTHMA; ALLERGIC DISEASE; ASTHMA; ATOPY; DRUG INDUSTRY; ECZEMA; FERMENTATION; FOOD ALLERGY; FOOD INDUSTRY; HUMAN; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; IMMUNOPATHOLOGY; IMMUNOPHARMACOLOGY; OXIDATIVE STRESS; PATHOGENESIS; PHENOTYPE; REVIEW; RHINITIS; SUPPRESSOR CELL; TH2 CELL;

EID: 0141813593     PISSN: 12123536     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (63)

1. Akira S. Mammalian Toll-like receptors. Curr Opin Immunol 2003; 15: 5-11.
2. Akira S, Hemmi H. Recognition of pathogen-associated molecular patterns by TLR family. Immunol Lett 2003; 85: 85-95.
3. Anderson GP, Coyle AJ. Th2 and Th2-like cells in allergy and asthma: pharmacological perspectives. Trends Pharmacol Sci 1994; 15: 324-332.
4. Arbour NC, Lorenz E, Schutte BC. TLR4 mutations are associated with endotoxin hyporesponsiveness in humans. Nature Genet 2000; 25: 187-191.
5. Baker JC, Ayres JG. Diet and asthma. Resp Med 2000; 94: 925-934.
6. Baldini M, Lohman IC, Halonen M, Erickson RP, Holt PG, Martinedz FD. A polymorphism in the 5-flanking region of the CD 14 gene is associated with circulating soluble CD 14 levels and with total serum immunoglobulin E. Am J Respiratory Cell Mol Biol 1999; 20: 976-983.
7. Biancone L, Monteleone I, Blanco GD, Vavassori P, Pallone F. Resident bacterial flora and immune system. Digest Liver Dis 2002; 34: 537-543.
8. Bohle B. CpG motifs as possible adjuvants for treatment of allergic diseases. Int Arch Allergy Immunol 2002; 129: 198-203.
9. Clancy R. Immunobiotics and the probiotic evolution. FEMS Immunol Med Microb 2003; 37: in press.
10. Cross ML. Microbes versus microbes: immune signals generated by probiotic lactobacilli and their role in protection against microbial pathogenes. FEMS Immunol Med Microb 2002; 34: 245-253.
11. Delgado M. VIP: a very important peptide in T helper differentiation. Trends Immunol 2003; 24: 245-253.
12. del Giudice MM, De Luca MG, Capristo C. Probiotics and atopic dermatitis. A new strategy in atopic dermatitis. Digest Liver Dis 2002; 34: S68-S71.
13. Ferenčík M. Funkčné vzfahy a prepojenia medzi imunitným a neuroendokrinným systémom. Alergie 2002; 4: 297-306.
14. Ferenčík M. Receptory podobné Toll (TLRs), prirodzená imunita a alergický zápal. Alergie 2003; 5: 30-37.
15. Ferenčík M, Ebringer L. Možnosti využitia probiotik v prevencii a terapii alergických chorôb. Alergia 2002; 4: 48-54.
16. Ferenčík M, Ebringer L. Vplyv selénu a zinku na imunitný systém. Klin Imunol Alergol 2002; 12/2: 9-18.
17. Ferenčik M, Pružinec P. Je alergická astma len imunologická choroba? Klin Imunol Alergol 2002; 12, č. 3: 5-9.
18. Fort MM, Cheung J, Yen D, Li J, Zurawski SM, Lo S, Menon S, Clifford T, Hunte B, Rennick DM. IL-25 induces IL-4, IL-5, and IL-13 and Th2-associated pathologies in vivo. Immunity 2001; 15: 985-995.
19. Frezzolini A, Paradisi M, Zaffiro A, Provini A, Cadoni S, Ruffelli M, De Pita O. Circulating interleukin 16 (IL-16) in children with atopic/eczema dermatitis syndrome (AEDS): a novel serological marker of disease activity. Allergy 2002; 57: 815-820.
20. Gazdik F, Horvathova M, Gazdikova K, Jahnova E. The influence of selenium supplementation on the immunity of corticoid-dependent asthmatics. Bratisl Lek Listy 2002; 103: 17-21.
21. Gazdik F, Kadrabova J, Gazdikova K. Decreased consumption of corticosteroids after selenium supplementation in corticoid-dependent asthmatics. Bratisl Lek Listy 2002; 103: 22-25.
22. Gorbach SL. Probiotics in the third millenium. Digest Liver Dis 2002; 34: S2-S7.
23. Hemmi H, Takeuchi O, Kawai T, Kaisho T, Sato S, Sanjo H, Matsumoto M, Hoshino K, Wagner H, Takeda K, Akira S. A Toll-like receptors recognizes bacterial DNA. Nature 2000; 408: 740-745.
24. Isolauri E, Arvola T, Sutas Y, Moilanen E, Salminen S. Probiotics in the management of atopic eczema. Clin Exp Allergy 2000; 30: 1604-1610.
25. Isolauri E, Rautava S, Kaliomaki M, Kirjavainen P, Salminen S. Role of probiotics in food hypersensitivity. Curr Opin Allergy Clin Immunol 2002; 2: 263-271.
26. Isolauri E, Sutas Y, Kankaapäá P, Arvilommi H, Salminen S. Probiotics: effect on immunity. Am J Clin Nutr 2001; 73: Suppl, 444S-450S.
27. Jahnova E, Horvathova M, Gazdik F, Weissova S. Effect of selenium supplementation on expression of adhesion molecules in corticoid-dependent asthmatics. Bratisl Lek Listy 2002; 103: 12-16.
28. Jeong DW, Yoo MH, Kim TS, Kim JH, Kim IY. Protection of mice from allergen-induced asthma by selenite: prevention of eosinophil infiltration by inhibition of NF-kappa B activation. J Biol Chem 2002; 277: 17871-17876.
29. Kalliomaki M, Isolauri E. Pandemic of atopic diseases - a lack of microbial exposure in early infancy? Curr Drug Targets Infect Disord 2002; 2: 193-199.
30. Kalliomaki M, Isolauri E. Role of intestinal flora in the development of allergy. Curr Opin Allergy Clin Immunol 2003; 3:15-20.
31. Kalliomaki M, Salminen S, Arrilommi H, Kero P, Koskinen P, Isolauri E. Probiotics in primary prevention of atopic desease: a randomised placebo-controlled trial. Lancet 2001; 357: 1076-1079.
32. Kalliomaki M, Salminen S, Poussa T, Arvilommi H, Isolauri E. Probiotics and prevention of atopic disease: 4-year follow-up a randimised placebo-controlled trial. Labcet 2003; 361: 1869-1871.
33. Kruse S, Kuehr J, Moseler M, Kopp MV, Kurz T, Deichmann KA, Foster PS, Mattes J. Polymorphisms in the IL-18 gene are associated with specific sensitization to common allergens and allergic rhinitis. J Allergy Clin Immunol 2003; 111: 117-122.
34. Laiho K, Ouwehand A, Salminen S, Isolauri E, Inventing probiotics functional foods for patients with allergic disease. Ann Allergy Asthma Immunol 2002; 89: 75-82 Suppl.
35. Leberge S, Pinsonneault S, Varga EM, Till SJ, Nouri-Aria K, Jacobson M, Cruikshank WW, Center DM Hamid Q, Durham SR. Increased expression of IL-16 immunoreactivity in bronchial mucosa after segmental allergen challenge in patients with asthma. J Allergy Clin Immunol 2000; 106: 293-301.
36. Lewis DB. Allergy immunotherapy and inhibition of Th2 immune responses: a sufficient strategy? Curr Opin Immunol 2002; 14: 644-651.
37. Lind A. Role of interleukin-17 and the neutrophil in asthma. Int Arch Allergy Immunol 2001; 126: 179-184.
38. Marteau P, Seksik P, Jian R. Probiotics and health: new facts and ideas. Curr Opin Biotechnol 2002; 13: 486-489.
39. Mellis CM. Is asthma prevention possible with dietary manipulation? Med J Australia 2002; 177: 578-580.
40. Mercenier A, Pavan S, Pot B. Probiotics as biotherapeutic agents: Present knowledge and future prospects. Curr Pharmaceu Design 2003; 9: 175-191.
41. Moro GE, Warm A, Arslanoglu S, Miniello V. Management of bovine protein allergy: new perspectives and nutritional aspects. Ann Allergy Asthma Immunol 2002; 89: 91-96 Suppl.
42. Nadeem A, Chhabra SK, Masood A, Raj HG, Increased oxidative stress and altered levels of antioxidants in asthma. J Allergy Clin Immunol 2003; 111: 72-78.
43. Nagao F, Nakayama M, Muto T, Okamura K. Effects of fermented milk drink containing Lactobacillus casei strain Shirota on the immune system in healthy human subjects. Biosci Biotechnol Biochem 2000; 64: 2706-2708.
44. Omland A, Deguchi Y, Sigsgaard T, Hansen JC. Selenium serum and urine is associated to mild asthma and atopy. The SUS study. J Trace Elem Med Biol 2002; 16: 123-127.
45. Pflanz S, Timans JC, Cheung J, Rosales R, Kunzler H, Gilbert J, Hibbert L, Rennick D, Kastelein RA. IL-27, a heterodimeric cytokine composed of EB 13 and p28 protein, induces proliferation of naive CD4(+) T cells. Immunity 2002; 16: 779-790.
46. Pinsonneault E, El Bassam S, Mazer B, Cruikshank WW, Laberge S. IL-16 inhibits IL-5 production by antigen stimulated T cells in atopic subjects. J Allergy Clin Immunol 2001; 107: 477-482.
47. Qujed D, Hidari B, Bijani K, Shirdel H. Glutathione peroxidase activity and serum selenium concentration in intrinsic asthmatic patients. Clin Chem Lab Med 2003; 41: 200-202.
48. Rautava S, Kalliomäki M, Isohuri E. Probiotics during pregnancy and breast-feeding might confer immunomodulatory protection against atopic disease in the infant. J Allergy Clin Immunol 2002; 109: 119-121.
49. Rayman MP. The importance of selenium to human health. Lancet 2000; 356: 233-241.
50. Renz H. The role of neurotrophins in bronchial asthma. Eur J Pharmacol 2001; 429: 231-237.
51. Rosenfeldt V, Benfeldt E, Nielsen SD, Michaelsen KF, Jeppesen DL, Valerius NH, Paerregaard A. Effect of probiotic Lactobacillus strains in children with atopic dermatitis. J Allergy Clin Immunol 2003; 111: 389-395.
52. Sabroe I, Parker LC, Wilson AG, Whyte MKB, Dower SK. Toll-like receptors: their role in allergy and non-allergic inflammatory disease. Clin Exp Allergy 2002; 32: 984-989.
53. Salvi SS, Babu KS, Holgate ST. Is asthma really due to a polarized T cell response toward a helper T cell type 2 phenotype? Am J Resp Crit Care Med 2001; 164: 1343-1346.
54. Schrezenmeir J, de Vrese M. Probiotics, prebiotics and synbiotics - approaching and definition. Am J Clin Nutr 2001; 73: Suppl, 361S-364S.
55. Singh B, Read S, Asseman C, Malstrom V, Mottet C, Stephens LA, Stepankova R, Tlaskalova H, Powrie F. Control of intestinal inflammation by regulatory T cells. Immunol Rev 2001; 182: 190-200.
56. Tanaka H, Miyazaki N, Oashi K, Teramoto S, Shiratori M, Hashimoto M, Ohmichi M, Abe S. IL-18 might reflect disease activity in mild and moderate asthma exacerbation. J Allergy Clin Immunol 2001; 107: 331-336.
57. Uhlman E, Vollmer J. Recent advances in the development of immunostimulatory oligonucleotides. Curr Opin Drug Discov Devel 2003; 6: 204-217.
58. Umetsu DT, McIntire JJ, Akbari O, Macaubas C, DeKruyff RH. Asthma: an epidemic of dysregulated immunity. Nature Immunol 2002; 3: 715-720.
59. van der Weid T, Ibnou-Zekri N, Pfeifer A. Novel probiotics for the management of allergic inflammation. Digest Liver Dis 2002; 34: S25-S28.
60. Verhaege B, Gevaert P, Holtappels G, Lukat KF, Lange B, Van Cauwenberge P, Bachert C. Up-regulation of IL-18 in allergic rhinitis. Allergy 2002; 57: 825-830.
61. von Mutius E. The environmental predictors of allergic disease. J Allergy Clin Immunol 2000; 105: 9-19.
62. Wild JS, Sur S. CpG oligonucleotide modulation of allergic inflammation. Allergy 2001; 56: 365-376.
63. Woodruff PG, Fahy JV. Asthma: prevalence, pathogenesis and prospects for novel therapies. JAMA 2001; 286: 395-398.